ArticleVaccines2024

Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITT.

Luisa Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.